The ubiquity of lactose intolerance around the world and the subsequent health issues are considered to be the prime dynamics for the growth of the neutral lactase market. On the back of the prevailing corporate world entangled with hectic schedules, the changing lifestyles across the globe have been severely affecting the food habits and health conditions of the millennial population across the world. Moreover, there is a decline in the immunity strength of people across the world. Consequently, a new wave of disorders surfaced where people have become allergic or incapable of digesting certain foods. One of the most common disorders in lactose intolerance, the inability to digest lactose, a sugar substance generally found in milk and other milk products. According to the National Center for Biotechnology Information (NCBI), the global prevalence of lactose intolerance was estimated to be around 70%.
The disorder is caused due to the deficiency of the lactase or beta-galactosidase enzyme. This enzyme is present in the small intestine and helps in digesting lactose by breaking it into glucose and galactose, which are directly dissolved in the bloodstream. Thus the deficiency of lactase enzyme leads to the indigestion of dairy products. This further leads to digestive symptoms such as abdominal pain, bloating, excess flatulence, diarrhea, and nausea after consuming foods or drinks containing lactose. To counter this problem, lactase was made available to the consumers as a food supplement by various dairy producers. Initially, all these products use acid lactase in a formulation that makes enzyme activity available in the stomach, which is destroyed within 15 to 45 min by gastric juice and consequently made it difficult for the user to find a dosage of the enzyme that facilitates complete degradation of the lactose taken up with food. This, as a consequence, fuelled the formulation of neutral lactase which is enteric-coated with shellac, thereby preventing the destruction of lactase by gastric juice. Therefore the growing prevalence of lactose intolerance in conjunction with the increasing concerns regarding digestive issues is proliferating the demand in the neutral lactase market.
As of 2018, the Global Neutral Lactase Market was evaluated to value at $120 million, and the demand for the product is poised to propel at a standard CAGR of 6.2% during the forecast period 2019-2025.
Increasing Consumption of Milk and Milk Related Products Creating Growth Prospects for the Neutral Lactase Market—
Based on application, milk is considered to be the key segment that is anticipated to create a significant demand influx in the neutral lactase market. This is mainly due to the increasing production of milk across the world. According to the Food and Agriculture Organization (FAO), the worldwide production of milk clocked 811 million tons in 2017, 1.4% more than in 2016, and it is projected to increase by 22% by 2027. Owing to the rising demand for lactose-free dairy products, the milk and milk products manufacturers are increasingly utilizing neutral lactase enzymes to develop the stated products. Thus the key application segment is poised to propel at a CAGR of 5.7% through to 2025.
Neutral Lactase Market Leveraging Dairy Producers in North America—
Geographically, North America was considered to be the major revenue generator for the neutral lactase market with a demand share of 36.5% in 2018, and it is estimated to secure its dominance throughout the forecast period. This is mainly attributed to the increasing consumption and milk and milk products in the region. The surge in the consumption of milk and related products can be perceived from the statistics furnished by Food and Agriculture Organization of the United Nations, according to which the amount of milk produced in North America was 1.8 million tones, a rise of 1.7% from 2016. Moreover, with the increasing incidence of lactose intolerance, the demand for easy digestible dairy products has uplifted, which further obligated the food manufacturers in the region to add lactase to their range of products, thus leading to an augmented demand for neutral lactase. The lactase enzyme is commonly used in the food industry to catalyze the hydrolysis of lactose for making lactose-free milk, probiotic yogurt, ice creams, and other delicacies. Therefore, the burgeoning food and beverage industries in developed nations, including the United States, Canada, and Mexico, is considered to be contributing significantly to the market growth. Moreover, on the back of technological advancements and increasing economic status, the people are becoming health conscious and preferring low-calorie diets and demanding food products low in sugar and lactose. As the health and wellness trend is instigating the people to eat healthier and hygienic food, the products produced by using lactase enzymes have gained a stand-out health appeal, which is ultimately propelling the growth of the neutral lactase enzyme market. These factors have rendered North America with maximum share.
Neutral Lactase Market Company’s Strategies—
Major companies that are crusading for the top share in the global neutral lactase market are Advanced Enzymes Technology Ltd., Chr. Hansen, DuPont, Amano Enzyme, Enzyme Development Corp., Royal DSM, Speciality Enzymes and Biotechnology, SternEnzym, and Novozymes. These companies are frequently investing in research and development activities to innovate novel products to build their brand name in the market. Moreover, the major players are adopting business strategies such as acquisitions, mergers, partnerships, expansions, and collaborations, to name a few. Some of the instances include:
· In July 2017, Advanced Enzyme Technologies Ltd., an Indian enzyme manufacturer, has announced its decision to acquire Evoxx Technologies, a German industrial biotech company. This strategy is implemented to expand the company’s research and development activities, and also to fortify its presence in Europe. Moreover, the acquisition is intended for its lactase enzyme portfolio and attract potential customers.
· In March 2018, Royal DSM, a global science-based company, launched the fastest neutral lactase enzyme, Maxilact Smart. This product increases the production efficiency sustainably and profitably, to meet the growing worldwide demand for lactose-free dairy. Moreover, this enzyme reduces your carbon footprint and energy consumption.
· In March 2016, Novozymes introduced an innovative lactase enzyme, Saphera, made from Bifidobacterium bifidum. This new enzyme facilitates precise measuring and attaining desired lactose level. Moreover, as it works at low pH and elevated temperatures, it can be used not only for the production of lactose-free milk and other products but also for fermented dairy products.
Talk to one of our sales representative about the full report by providing your details in the link below:
a) Lactose-Free Food Market
b) Dairy Protein Market
Any other custom requirements can be discussed with our team, drop an e-mail to [email protected] to discuss more about our consulting services.
To request for a quote, provide your details in the below link:
Mr. Venkat Reddy
Email: [email protected]
About IndustryARC: IndustryARC is a Research and Consulting Firm that publishes more than 500 reports annually, in various industries such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food and Beverages, Information Technology, and Life sciences and Healthcare.